This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

For patients on a 12-month plan, Hims offers a semaglutide injection for $199 a month. Ozempic and Wegovy carry high list prices of $935.77 and $1,349.02, respectively, for a month’s supply, according ...

A new study found that people taking Wegovy during the pandemic were 33 percent less likely to die of COVID-19.

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...

Share on Pinterest Getty Images/nortonrsx Wegovy (semaglutide) is an injectable prescription medication that’s approved by the Food and Drug Administration (FDA) for chronic weight management in ...

A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...

Novo Nordisk’s oral obesity pill, amycretin, showed faster weight loss than its blockbuster weekly injection for chronic weight management, Wegovy (semaglutide), in the phase I study.

A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, ...